Internal Medicine, Hematology & Oncology · Downey, CA
NPI
1932436821
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11480 Brookshire Ave, Suite 309
Downey, CA, 90241
Phone (562) 869-1201
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
96,360 services
Medicare patients, 2024
362
Average age 75
Drug cost, 2024
$5.7M
1,940 prescriptions
Company payments, 2025
$5,786
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eddie Thara was code J0897 (injection, denosumab, 1 mg), 4,680 times for 17 patients. In total Eddie Thara billed 96,360 services in 105 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,680 | 17 | $20.64 | $97K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,030 | 32 | $0.09 | $272 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,400 | 14 | $15.79 | $38K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,008 | 22 | $0.07 | $74.21 |
| 99232 Hospital E&M - Subsequent | Facility | 644 | 151 | $64.93 | $42K |
| 96367 Intravenous Infusion, Hydration | Office | 366 | 34 | $25.36 | $9,282 |
| 96372 Injection Administration | Office | 265 | 37 | $12.33 | $3,269 |
| 96413 Chemotherapy Administration | Office | 245 | 40 | $118.02 | $29K |
| 99215 Office E&M - Established | Office | 244 | 87 | $147.32 | $36K |
| 99214 Office E&M - Established | Office | 195 | 91 | $103.95 | $20K |
| 99223 Hospital E&M - Initial | Facility | 181 | 159 | $141.63 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 171 | 92 | $13.70 | $2,343 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 145 | 19 | $0.64 | $93.3 |
| 96417 Chemotherapy Administration | Office | 120 | 19 | $56.85 | $6,822 |
| 96415 Chemotherapy Administration | Office | 100 | 20 | $24.76 | $2,476 |
By year: 2022 $145K for 9,932 services; 2023 $638K for 39,134 services; 2024 $2.0M for 96,360 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eddie Thara prescribed most often to Medicare patients was Prednisone, with 179 prescriptions and refills. In total Eddie Thara wrote 1,940 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 179 | 190 | 30 | $702 |
| Abiraterone Acetate Generic | 166 | 172 | 22 | $551K |
| Anastrozole Generic | 99 | 292 | 46 | $1,994 |
| Dexamethasone Sodium Phosphate Generic | 94 | 100 | 25 | $302 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 88 | 92 | 25 | $134 |
| Eliquis Apixaban | 71 | 147 | 28 | $82K |
| Famotidine Famotidine/Pf | 67 | 73 | 19 | $79.45 |
| Diphenhydramine Hcl Generic | 63 | 65 | 19 | $142 |
| Lupron Depot Leuprolide Acetate | 58 | 162 | 18 | $292K |
| Ondansetron Odt Ondansetron | 52 | 52 | 27 | $559 |
| Oxaliplatin Generic | 43 | 43 | 12 | $7,054 |
| Letrozole Generic | 37 | 94 | 15 | $854 |
| Dexamethasone Generic | 36 | 44 | 16 | $930 |
| Hydroxyurea Generic | 32 | 83 | 11 | $1,228 |
| Lenalidomide Generic | 29 | 29 | Under 11 | $358K |
Brand drugs: 530 claims; generic drugs: 1,410 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eddie Thara $5,786 ($5,786 in general payments such as food, travel and fees) from 48 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $506.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $506 |
| Pfizer Inc. PFE | 17 | $439 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $418 |
| Abbvie Inc. ABBV | 14 | $277 |
| Janssen Biotech, Inc. JNJ | 10 | $274 |
| Incyte Corporation INCY | 8 | $252 |
| Daiichi Sankyo Inc. 4568.T | 9 | $249 |
| Merck Sharp & Dohme LLC MRK | 9 | $237 |
| Celgene Corporation BMY | 5 | $232 |
| BeOne Medicines USA, Inc. ONC | 3 | $218 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.